Brief: Eurobio Scientific, Acobiom Sign Commercial Deal
22/11/2022 16:51
Nov 22 (Reuters) - EUROBIO SCIENTIFIC SA ALERS.PA :
* EUROBIO SCIENTIFIC AND ACOBIOM ANNOUNCE THE SIGNATURE OF A
COMMERCIAL AGREEMENT FOR THE EXCLUSIVE DISTRIBUTION OF A
PREDICTIVE DIAGNOSTIC RESPONSE TEST
Source text for Eikon: ID:nGNE9qMxVN
Further company coverage: ALERS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))
Recent news on Eurobio Scientific SA
See all newsBrief: Eurobio Scientific EB Development Files Public Offer For Shares
Brief: Eurobio Scientific Says At End Of June 2024, Recorded Revenues Of 73.4 Mln Euros, Compared With 59.1 Mln Euros A Year Ago
Brief: Eurobio Scientific FY Core Business Revenues Up At EUR 130 Mln
Brief: Eurobio Scientific Cancels 694,300 Treasury Shares, Representing Around 6.34% Of Share Capital
Brief: Eurobio Scientific H1 Ebitda Up To EUR 13.4 Million